Myeloma Clinical Scholar, Faculty Physician (Associate/Professor)
Apply NowCompany: Rutgers University
Location: Piscataway, NJ 08854
Description:
Position Details
Position Information
Recruitment/Posting Title
Myeloma Clinical Scholar, Faculty Physician (Associate/Professor)
Department
CINJ Medical - Heme Malig
Salary
Commensurate With Experience
Posting Summary
Rutgers Cancer Institute seeks an mid- to senior-level academically oriented hematologist/oncologist for a clinical research position with a clinical focus in myeloma, a record of original clinical research, and exceptional clinical and leadership skills. Unique opportunities exist for collaborations between clinical enterprise at RWJ Barnabas Health and research programs at Rutgers Cancer Institute. Research programs at Rutgers Cancer Institute include: Cancer Metabolism and Immunology, Genomic Instability and Cancer Genetics, Cancer Pharmacology, Clinical Investigations and Precision Therapeutics, and Cancer Prevention and ControlThere are a broad range of teaching opportunities with medical students, house staff, and fellows. Academic rank (Associate Professor/Professor) and clinical research support commensurate with experience. Uniquely qualified candidates may be considered for additional leadership responsibilities as Section Head for Hematologic Malignancy.
As a National Cancer Institute (NCI) Designated Comprehensive Cancer Center, Rutgers Cancer Institute is a leader in high-intensity cancer care, offering comprehensive hematology/oncology clinical programs. Partnering with RWJBarnabas Health, the state's largest health care delivery system, we provide sophisticated oncology care to patients close to home. This integrated cancer care model offers access to advanced diagnostic and treatment options, including clinical trials, immunotherapy, proton therapy, precision medicine, CAR T-cell therapy, and cardio-oncology. Become part of our innovative team and make history as we unveil the groundbreaking Jack and Sheryl Morris Cancer Center-a 12-story, 520,000 square foot freestanding cancer hospital, the first of its kind in New Jersey. Explore the state-of-the-art facility here and discover more about our groundbreaking initiatives at www.cinj.org.
The academic appointment will be within the Rutgers Robert Wood Johnson Medical School and located in New Brunswick, NJ. Faculty members are expected to support the educational goals of the school, engaging in teaching activities for medical students and residents, as well as delivering targeted lectures in their area of expertise.
Apply now and contribute to our commitment to excellence in patient care, research, and education! For questions on this position or to learn more about our available positions, please contact the Rutgers Cancer Institute Faculty Recruitment Office at .
See all our open faculty positions here!
Position Status
Full Time
Posting Number
24FA1087
Posting Open Date
10/18/2024
Posting Close Date
Qualifications
Minimum Education and Experience
Qualified candidates must have:
Candidates with experience and expertise in conducting and leading clinical research are preferred.
Certifications/Licenses
Required Knowledge, Skills, and Abilities
Equipment Utilized
Physical Demands and Work Environment
Overview
RBHS
New Jersey's premier academic health center, Rutgers Biomedical and Health Sciences (RBHS) takes an integrated approach to educating students, providing clinical care, and conducting research, all with the goal of improving human health. Aligned with Rutgers University-New Brunswick and collaborating university wide, RBHS includes eight schools, a behavioral health network, and five centers and institutes that focus on cancer treatment and research, neuroscience, advanced biotechnology and medicine, environmental and occupational health, and health care policy and aging research. Our renowned faculty are teachers, health researchers and providers, and scientists with unparalleled experience who advance medical innovation and provide patient care informed by the latest research findings. We offer an outstanding education and training in medicine, dentistry, pharmacy, public health, nursing, biomedical research, and the full spectrum of allied health careers. An important mission of RBHS is to promote the careers of faculty, staff, and learners. Through this community of healers, scientists, and scholars, Rutgers is equipped as never before to transform lives.
Rutgers Robert Wood Johnson Medical SchoolAs one of the nation's comprehensive medical schools, Rutgers Robert Wood Johnson Medical School (RWJMS) is dedicated to pursuing excellence in education, research, healthcare delivery, and the promotion of community health. In cooperation with Robert Wood Johnson University Hospital, the medical school's principal affiliate, they comprise New Jersey's premier academic medical center. In addition, RWJMS has 34 other hospital affiliates and ambulatory care sites throughout the region. RWJMS encompasses 20 basic science and clinical departments and hosts centers and institutes, described below. The medical school maintains undergraduate, graduate, and postgraduate educational programs for more than 1,500 students on its campuses in New Brunswick and Piscataway. It provides continuing education courses for healthcare professionals and community education programs. Previously an academic unit of the University of Medicine and Dentistry of New Jersey, RWJMS became part of Rutgers, The State University of New Jersey, as part of the New Jersey Medical and Health Sciences Education Restructuring Act, on July 1, 2013.
Rutgers Cancer Institute
As New Jersey's only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute, in partnership with RWJBarnabas Health, is a leader in cancer research, treatment, prevention, and education. Rutgers Cancer Institute offers world-class cancer care, providing patients with the most advanced treatment options through an integrated cancer care network, including clinical trials, immunotherapy, precision medicine, complex surgical procedures, and sophisticated radiation therapy techniques. Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, are one of only two programs in the state to offer blood and marrow transplantations and CAR T-cell therapy. It also houses the state's only hospital-based proton therapy center. Rutgers Cancer Institute is a cornerstone of New Jersey's premier academic health center, Rutgers Biomedical and Health Sciences (RBHS).
Construction is currently underway for a new $750 million state-of-the-art Cancer Center adjacent to the current Rutgers Cancer Institute facility and Robert Wood Johnson University Hospital. The 510,000 square foot Jack and Sheryl Morris Cancer Center will be the state's first free-standing cancer hospital. It will feature outpatient and inpatient clinical space-including 84 infusion bays, 74 exam rooms, and 96 inpatient beds. This is in addition to state-of-the-art laboratories where critical scientific investigation will be amplified, enabling physician-scientists to translate findings directly to patients. The Jack and Sheryl Morris Cancer Center will also have the capacity to offer wellness and education resources all in one location. Learn more about this incredible facility at www.cinj.org/jackandsherylmorriscancercenter
Rutgers Cancer Institute is home to nearly 250 internationally recognized physicians and researchers. The long-standing relationship with their NCI Research Consortium Partner Princeton University was recently leveraged to establish the Ludwig Cancer Research Princeton Branch with several faculty as founding members and leaders of the Branch. Their work on cancer metabolism, not only through the new Ludwig Branch but also through the Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence at Rutgers Cancer Institute, will accelerate and translate laboratory discoveries into clinical treatments through more effective and efficiently designed clinical trials.
The Rutgers Cancer Institute's Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence is an institute at the intersection of oncologic immunology and metabolism that seeks to increase research that leads to new therapies for patients; develop cutting-edge facilities to test new interventions; and facilitate commercial and university collaborations. This includes discovery and production of novel cell therapy constructs via an institutional good manufactory practices (GMP) facility. Visit Center of Excellence in Cancer Immunology and Metabolism.
Division of Blood DisordersThe multidisciplinary team of experts within the Hematologic Malignancies Program combines exceptional expertise, knowledge, and skill with advanced therapies to treat benign and malignant blood disorders in a comprehensive and compassionate environment. Physicians are among the nation's most experienced with expertise in routine, rare and complex hematologic malignancies, treating advanced blood cancers with clinical trials, immunotherapy, and other cellular therapies.
Rutgers Cancer Institute is one of the first programs in the state to offer CAR T-cell therapy and other novel cell therapy constructs. The Program's approach to cancer care offers the full spectrum of therapeutic procedures and advanced treatment options for patients with acute and chronic leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, myelodysplasia, myeloproliferative diseases, and other hematologic malignancies. Rutgers Cancer Institute, in collaboration with Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, is home to one of only two blood and marrow transplant programs in the state and the only one at an NCI-designated Comprehensive Cancer Center. In addition, Rutgers Cancer Institute is recognized as a Center of Excellence by the Myelodysplastic Syndromes (MDS) Foundation in the research, diagnosis, and treatment of MDS disorders.
The Division of Blood Disorders is organized in the Rutgers Robert Wood Johnson Medical School Department of Internal Medicine, and these provide specialized care for patients with complex conditions. Physicians practice in multiple specialized and statewide referral centers and programs. Hematologists/Oncologists and blood and marrow transplanters with significant expertise in various malignant and benign hematologic disorders participate in providing innovative, comprehensive diagnosis and treatment.
Rutgers Cancer Institute is committed to retaining, recruiting, and developing outstanding faculty, staff, and students, including those traditionally underrepresented in medicine in faculty, staff, and student bodies. It aspires to be an agent of progress in advancing equality and justice while improving healthcare access and reducing healthcare disparities. Visit us here.More information on our community here.
Statement
Rutgers Cancer Institute, the state's only NCI-designated Comprehensive Cancer Center and RWJBarnabas Health, the state's largest health care delivery system partner to deliver high-quality and sophisticated oncology care to patients close to home. This integrated cancer care model combines the strength of both entities, offering access to the most advanced diagnostic and treatment options for adult and pediatric cancer patients, including clinical trials, immunotherapy, proton therapy, precision medicine, CAR T-cell therapy and cardio-oncology. Through the above mentioned partnership and an academic appointment at Rutgers, The State University of New Jersey, unique opportunities exist for collaborations between clinical and research programs, including clinical trials research, cancer chemoprevention, clinical and basic pharmacology, and Phase 1 clinical trials.
Mission
To accelerate scientific discovery focused on understanding cancer, innovating cancer treatment, and improving cancer prevention; to provide outstanding, novel, and compassionate patient care; to provide evidence-based and culturally informed education to physicians, nurses, researchers, staff, and the community; and to achieve cancer health equity in our state through outreach to and engagement of our extraordinarily diverse communities
Vision
Through our science, our evidence-based actions, our openness, and our respect for those we serve, we will advance cancer-focused research worldwide and reduce the burden of cancer in our catchment area. By engaging with and empowering our exceptionally diverse populations, and addressing their questions and fears, we will engender hope for cancer patients and their families and play a critical role in strengthening the fabric of our communities by gaining and protecting their trust and providing access to the outstanding oncology care each person deserves.
Core Values
Curiosity and Discovery: encouraging an environment of continuous inquiry, creativity, and innovation to generate new knowledge
Integrity: earning the trust of those we serve and each other through honesty, transparency, accountability, and continuous reflection
Collaboration: approaching all opportunities with an understanding that together we are better and can achieve more; promoting and maintaining an environment of teamwork and shared knowledge
Cultivating Diversity: making conscientious efforts in all we do to ensure that our leadership, scientists, clinicians, supporting staff, and trainees reflect the rich diversity of the state of New Jersey and the patient populations and communities we serve
Position Information
Recruitment/Posting Title
Myeloma Clinical Scholar, Faculty Physician (Associate/Professor)
Department
CINJ Medical - Heme Malig
Salary
Commensurate With Experience
Posting Summary
Rutgers Cancer Institute seeks an mid- to senior-level academically oriented hematologist/oncologist for a clinical research position with a clinical focus in myeloma, a record of original clinical research, and exceptional clinical and leadership skills. Unique opportunities exist for collaborations between clinical enterprise at RWJ Barnabas Health and research programs at Rutgers Cancer Institute. Research programs at Rutgers Cancer Institute include: Cancer Metabolism and Immunology, Genomic Instability and Cancer Genetics, Cancer Pharmacology, Clinical Investigations and Precision Therapeutics, and Cancer Prevention and ControlThere are a broad range of teaching opportunities with medical students, house staff, and fellows. Academic rank (Associate Professor/Professor) and clinical research support commensurate with experience. Uniquely qualified candidates may be considered for additional leadership responsibilities as Section Head for Hematologic Malignancy.
As a National Cancer Institute (NCI) Designated Comprehensive Cancer Center, Rutgers Cancer Institute is a leader in high-intensity cancer care, offering comprehensive hematology/oncology clinical programs. Partnering with RWJBarnabas Health, the state's largest health care delivery system, we provide sophisticated oncology care to patients close to home. This integrated cancer care model offers access to advanced diagnostic and treatment options, including clinical trials, immunotherapy, proton therapy, precision medicine, CAR T-cell therapy, and cardio-oncology. Become part of our innovative team and make history as we unveil the groundbreaking Jack and Sheryl Morris Cancer Center-a 12-story, 520,000 square foot freestanding cancer hospital, the first of its kind in New Jersey. Explore the state-of-the-art facility here and discover more about our groundbreaking initiatives at www.cinj.org.
The academic appointment will be within the Rutgers Robert Wood Johnson Medical School and located in New Brunswick, NJ. Faculty members are expected to support the educational goals of the school, engaging in teaching activities for medical students and residents, as well as delivering targeted lectures in their area of expertise.
Apply now and contribute to our commitment to excellence in patient care, research, and education! For questions on this position or to learn more about our available positions, please contact the Rutgers Cancer Institute Faculty Recruitment Office at .
See all our open faculty positions here!
Position Status
Full Time
Posting Number
24FA1087
Posting Open Date
10/18/2024
Posting Close Date
Qualifications
Minimum Education and Experience
Qualified candidates must have:
- MD/DO/MBBS
- ABIM eligible/certified
- Completed a 3-year hematology/oncology fellowship
- Have active/be eligible for NJ Medical License
- Have clinical and research productivity to support academic rank of Associate Professor/Professor
Candidates with experience and expertise in conducting and leading clinical research are preferred.
Certifications/Licenses
Required Knowledge, Skills, and Abilities
Equipment Utilized
Physical Demands and Work Environment
Overview
RBHS
New Jersey's premier academic health center, Rutgers Biomedical and Health Sciences (RBHS) takes an integrated approach to educating students, providing clinical care, and conducting research, all with the goal of improving human health. Aligned with Rutgers University-New Brunswick and collaborating university wide, RBHS includes eight schools, a behavioral health network, and five centers and institutes that focus on cancer treatment and research, neuroscience, advanced biotechnology and medicine, environmental and occupational health, and health care policy and aging research. Our renowned faculty are teachers, health researchers and providers, and scientists with unparalleled experience who advance medical innovation and provide patient care informed by the latest research findings. We offer an outstanding education and training in medicine, dentistry, pharmacy, public health, nursing, biomedical research, and the full spectrum of allied health careers. An important mission of RBHS is to promote the careers of faculty, staff, and learners. Through this community of healers, scientists, and scholars, Rutgers is equipped as never before to transform lives.
Rutgers Robert Wood Johnson Medical SchoolAs one of the nation's comprehensive medical schools, Rutgers Robert Wood Johnson Medical School (RWJMS) is dedicated to pursuing excellence in education, research, healthcare delivery, and the promotion of community health. In cooperation with Robert Wood Johnson University Hospital, the medical school's principal affiliate, they comprise New Jersey's premier academic medical center. In addition, RWJMS has 34 other hospital affiliates and ambulatory care sites throughout the region. RWJMS encompasses 20 basic science and clinical departments and hosts centers and institutes, described below. The medical school maintains undergraduate, graduate, and postgraduate educational programs for more than 1,500 students on its campuses in New Brunswick and Piscataway. It provides continuing education courses for healthcare professionals and community education programs. Previously an academic unit of the University of Medicine and Dentistry of New Jersey, RWJMS became part of Rutgers, The State University of New Jersey, as part of the New Jersey Medical and Health Sciences Education Restructuring Act, on July 1, 2013.
Rutgers Cancer Institute
As New Jersey's only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute, in partnership with RWJBarnabas Health, is a leader in cancer research, treatment, prevention, and education. Rutgers Cancer Institute offers world-class cancer care, providing patients with the most advanced treatment options through an integrated cancer care network, including clinical trials, immunotherapy, precision medicine, complex surgical procedures, and sophisticated radiation therapy techniques. Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, are one of only two programs in the state to offer blood and marrow transplantations and CAR T-cell therapy. It also houses the state's only hospital-based proton therapy center. Rutgers Cancer Institute is a cornerstone of New Jersey's premier academic health center, Rutgers Biomedical and Health Sciences (RBHS).
Construction is currently underway for a new $750 million state-of-the-art Cancer Center adjacent to the current Rutgers Cancer Institute facility and Robert Wood Johnson University Hospital. The 510,000 square foot Jack and Sheryl Morris Cancer Center will be the state's first free-standing cancer hospital. It will feature outpatient and inpatient clinical space-including 84 infusion bays, 74 exam rooms, and 96 inpatient beds. This is in addition to state-of-the-art laboratories where critical scientific investigation will be amplified, enabling physician-scientists to translate findings directly to patients. The Jack and Sheryl Morris Cancer Center will also have the capacity to offer wellness and education resources all in one location. Learn more about this incredible facility at www.cinj.org/jackandsherylmorriscancercenter
Rutgers Cancer Institute is home to nearly 250 internationally recognized physicians and researchers. The long-standing relationship with their NCI Research Consortium Partner Princeton University was recently leveraged to establish the Ludwig Cancer Research Princeton Branch with several faculty as founding members and leaders of the Branch. Their work on cancer metabolism, not only through the new Ludwig Branch but also through the Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence at Rutgers Cancer Institute, will accelerate and translate laboratory discoveries into clinical treatments through more effective and efficiently designed clinical trials.
The Rutgers Cancer Institute's Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence is an institute at the intersection of oncologic immunology and metabolism that seeks to increase research that leads to new therapies for patients; develop cutting-edge facilities to test new interventions; and facilitate commercial and university collaborations. This includes discovery and production of novel cell therapy constructs via an institutional good manufactory practices (GMP) facility. Visit Center of Excellence in Cancer Immunology and Metabolism.
Division of Blood DisordersThe multidisciplinary team of experts within the Hematologic Malignancies Program combines exceptional expertise, knowledge, and skill with advanced therapies to treat benign and malignant blood disorders in a comprehensive and compassionate environment. Physicians are among the nation's most experienced with expertise in routine, rare and complex hematologic malignancies, treating advanced blood cancers with clinical trials, immunotherapy, and other cellular therapies.
Rutgers Cancer Institute is one of the first programs in the state to offer CAR T-cell therapy and other novel cell therapy constructs. The Program's approach to cancer care offers the full spectrum of therapeutic procedures and advanced treatment options for patients with acute and chronic leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, myelodysplasia, myeloproliferative diseases, and other hematologic malignancies. Rutgers Cancer Institute, in collaboration with Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, is home to one of only two blood and marrow transplant programs in the state and the only one at an NCI-designated Comprehensive Cancer Center. In addition, Rutgers Cancer Institute is recognized as a Center of Excellence by the Myelodysplastic Syndromes (MDS) Foundation in the research, diagnosis, and treatment of MDS disorders.
The Division of Blood Disorders is organized in the Rutgers Robert Wood Johnson Medical School Department of Internal Medicine, and these provide specialized care for patients with complex conditions. Physicians practice in multiple specialized and statewide referral centers and programs. Hematologists/Oncologists and blood and marrow transplanters with significant expertise in various malignant and benign hematologic disorders participate in providing innovative, comprehensive diagnosis and treatment.
Rutgers Cancer Institute is committed to retaining, recruiting, and developing outstanding faculty, staff, and students, including those traditionally underrepresented in medicine in faculty, staff, and student bodies. It aspires to be an agent of progress in advancing equality and justice while improving healthcare access and reducing healthcare disparities. Visit us here.More information on our community here.
Statement
Rutgers Cancer Institute, the state's only NCI-designated Comprehensive Cancer Center and RWJBarnabas Health, the state's largest health care delivery system partner to deliver high-quality and sophisticated oncology care to patients close to home. This integrated cancer care model combines the strength of both entities, offering access to the most advanced diagnostic and treatment options for adult and pediatric cancer patients, including clinical trials, immunotherapy, proton therapy, precision medicine, CAR T-cell therapy and cardio-oncology. Through the above mentioned partnership and an academic appointment at Rutgers, The State University of New Jersey, unique opportunities exist for collaborations between clinical and research programs, including clinical trials research, cancer chemoprevention, clinical and basic pharmacology, and Phase 1 clinical trials.
Mission
To accelerate scientific discovery focused on understanding cancer, innovating cancer treatment, and improving cancer prevention; to provide outstanding, novel, and compassionate patient care; to provide evidence-based and culturally informed education to physicians, nurses, researchers, staff, and the community; and to achieve cancer health equity in our state through outreach to and engagement of our extraordinarily diverse communities
Vision
Through our science, our evidence-based actions, our openness, and our respect for those we serve, we will advance cancer-focused research worldwide and reduce the burden of cancer in our catchment area. By engaging with and empowering our exceptionally diverse populations, and addressing their questions and fears, we will engender hope for cancer patients and their families and play a critical role in strengthening the fabric of our communities by gaining and protecting their trust and providing access to the outstanding oncology care each person deserves.
Core Values
Curiosity and Discovery: encouraging an environment of continuous inquiry, creativity, and innovation to generate new knowledge
Integrity: earning the trust of those we serve and each other through honesty, transparency, accountability, and continuous reflection
Collaboration: approaching all opportunities with an understanding that together we are better and can achieve more; promoting and maintaining an environment of teamwork and shared knowledge
Cultivating Diversity: making conscientious efforts in all we do to ensure that our leadership, scientists, clinicians, supporting staff, and trainees reflect the rich diversity of the state of New Jersey and the patient populations and communities we serve